These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 28027910)
1. Pharmacological chaperone approaches for rescuing GPCR mutants: Current state, challenges, and screening strategies. Beerepoot P; Nazari R; Salahpour A Pharmacol Res; 2017 Mar; 117():242-251. PubMed ID: 28027910 [TBL] [Abstract][Full Text] [Related]
2. Chaperoning G protein-coupled receptors: from cell biology to therapeutics. Tao YX; Conn PM Endocr Rev; 2014 Aug; 35(4):602-47. PubMed ID: 24661201 [TBL] [Abstract][Full Text] [Related]
3. Molecular chaperones and G protein-coupled receptor maturation and pharmacology. Tao YX Mol Cell Endocrinol; 2020 Jul; 511():110862. PubMed ID: 32389798 [TBL] [Abstract][Full Text] [Related]
4. Specific ligands as pharmacological chaperones: The transport of misfolded G-protein coupled receptors to the cell surface. Nakamura M; Yasuda D; Hirota N; Shimizu T IUBMB Life; 2010 Jun; 62(6):453-9. PubMed ID: 20503438 [TBL] [Abstract][Full Text] [Related]
8. Rescue of Cell Surface Expression and Signaling of Mutant Follicle-Stimulating Hormone Receptors. Hanyroup S; Anderson RC; Nataraja S; Yu HN; Millar RP; Newton CL Endocrinology; 2021 Dec; 162(12):. PubMed ID: 34192304 [TBL] [Abstract][Full Text] [Related]
9. Rescue of Function of Mutant Luteinising Hormone Receptors with Deficiencies in Cell Surface Expression, Hormone Binding, and Hormone Signalling. Newton CL; Anderson RC; Kreuchwig A; Krause G; Katz AA; Millar RP Neuroendocrinology; 2021; 111(5):451-464. PubMed ID: 32316022 [TBL] [Abstract][Full Text] [Related]
10. Functional Rescue of Inactivating Mutations of the Human Neurokinin 3 Receptor Using Pharmacological Chaperones. Anderson RC; Hanyroup S; Song YB; Mohamed-Moosa Z; van den Bout I; Schwulst AC; Kaiser UB; Millar RP; Newton CL Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562976 [TBL] [Abstract][Full Text] [Related]
11. Regulation of GPCR Anterograde Trafficking by Molecular Chaperones and Motifs. Young B; Wertman J; Dupré DJ Prog Mol Biol Transl Sci; 2015; 132():289-305. PubMed ID: 26055064 [TBL] [Abstract][Full Text] [Related]
12. Intracellularly located misfolded glycoprotein hormone receptors associate with different chaperone proteins than their cognate wild-type receptors. Mizrachi D; Segaloff DL Mol Endocrinol; 2004 Jul; 18(7):1768-77. PubMed ID: 15105436 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological chaperones correct misfolded GPCRs and rescue function: protein trafficking as a therapeutic target. Maya-Núñez G; Ulloa-Aguirre A; Janovick JA; Conn PM Subcell Biochem; 2012; 63():263-89. PubMed ID: 23161143 [TBL] [Abstract][Full Text] [Related]
14. Early Stage Discovery and Validation of Pharmacological Chaperones for the Correction of Protein Misfolding Diseases. Aubi O; Knappskog PM; Martinez A Methods Mol Biol; 2019; 1873():279-292. PubMed ID: 30341617 [TBL] [Abstract][Full Text] [Related]
15. Pharmacoperone drugs: targeting misfolded proteins causing lysosomal storage-, ion channels-, and G protein-coupled receptors-associated conformational disorders. Hou ZS; Ulloa-Aguirre A; Tao YX Expert Rev Clin Pharmacol; 2018 Jun; 11(6):611-624. PubMed ID: 29851355 [TBL] [Abstract][Full Text] [Related]
16. ANKRD13C acts as a molecular chaperone for G protein-coupled receptors. Parent A; Roy SJ; Iorio-Morin C; Lépine MC; Labrecque P; Gallant MA; Slipetz D; Parent JL J Biol Chem; 2010 Dec; 285(52):40838-51. PubMed ID: 20959461 [TBL] [Abstract][Full Text] [Related]
17. Using pharmacological chaperones to restore proteostasis. Wang YJ; Di XJ; Mu TW Pharmacol Res; 2014 May; 83():3-9. PubMed ID: 24747662 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological chaperoning: a primer on mechanism and pharmacology. Leidenheimer NJ; Ryder KG Pharmacol Res; 2014 May; 83():10-9. PubMed ID: 24530489 [TBL] [Abstract][Full Text] [Related]
19. Targeting trafficking as a therapeutic avenue for misfolded GPCRs leading to endocrine diseases. Ulloa-Aguirre A; Zariñán T; Gutiérrez-Sagal R; Tao YX Front Endocrinol (Lausanne); 2022; 13():934685. PubMed ID: 36093106 [TBL] [Abstract][Full Text] [Related]
20. Use of Kikume green-red fusions to study the influence of pharmacological chaperones on trafficking of G protein-coupled receptors. Ridelis I; Schmidt A; Teichmann A; Furkert J; Wiesner B; Schülein R FEBS Lett; 2012 Mar; 586(6):784-91. PubMed ID: 22306118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]